European Archives - Page 35 of 1343 - European Medical Journal

myopia

Imaging Study Reveals New Clues in Severe Short-Sightedness

PS-OCT reveals distinct scleral fibre changes in pathologic myopia, offering new clues to prevent vision loss.

sickle cell

Experts Set New Standards to Improve Sickle Cell Care

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with sickle cell disease.

ABPA Case Broadens Understanding of Rare Pleural Complications - EMJ

ABPA Case Broadens Understanding of Rare Pleural Complications

A rare case of ABPA presenting as pyopneumothorax highlights the need for early recognition of pleural complications in asthmatic patients.

Long-Acting Therapeutics for HIV

Key takeaways from the symposia. Impact of LA options on the future of treatment and prevention. Opportunities and challenges for…

4 Dec 2025

Evidence on VNS in the Modern DRE Treatment Landscape

In this interactive article, explore how drug-resistant epilepsy is linked to decreased quality of life and increased risk of morbidity and..

Clinical trial participant

ABPI: UK falling behind on clinical trial recruitment

According to the body, patient participation in industry-sponsored trials has fallen by 25% between 2022/23 and 2024/25.

Aluminum Adjuvant Imject Alum Drives Liver Fibrosis in Novel Mouse Model

High-dose aluminum adjuvant Imject Alum induces immune-mediated liver inflammation and fibrosis in mice, offering a new preclinical model that mirrors human cirrhosis biology.

New Guideline Enhances Safe csDMARD Use Nationwide

BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.

glioblastoma

Engineered Virus Shows New Hope Against Deadly Brain Cancer

Engineered herpes virus targets glioblastoma cells, destroying tumours while activating immune defences in preclinical brain cancer models.

Anna Minchom, Royal Marsden Hospital and the Institute of Cancer Research, London.

Onc Now: Episode 31: Tackling Drug Resistance and Shaping New Therapies

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.